Covered recipient · General Payments record
FRANK P ALBINO
Allopathic & Osteopathic Physicians Plastic Surgery
General Payments · PY2018–2024
$33,310.43
- Reported across 258 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $820.11 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| MOTIVA USA, LLC | $272.91 | 4 |
| ABBVIE INC. | $257.15 | 7 |
| AXOGEN | $125.83 | 2 |
| TELA Bio, Inc. | $69.98 | 1 |
| REVANCE THERAPEUTICS, INC. | $52.63 | 1 |
| DAVOL INC. | $23.81 | 1 |
| Solta Medical, a division of Bausch Health US, LLC | $17.80 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $32.07 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103198125 | CMS |
| ABBVIE INC. | $24.76 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103198127 | CMS |
| ABBVIE INC. | $136.45 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103198129 | CMS |
| ABBVIE INC. | $4.84 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103198131 | CMS |
| ABBVIE INC. | $18.96 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103198133 | CMS |
| ABBVIE INC. | $16.95 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103198135 | CMS |
| ABBVIE INC. | $23.12 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103198137 | CMS |
| AXOGEN | $29.86 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143637413 | CMS |
| AXOGEN | $95.97 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143642761 | CMS |
| Davol Inc. | $23.81 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127654752 | CMS |
| MOTIVA USA, LLC | $64.32 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139154300 | CMS |
| MOTIVA USA, LLC | $10.98 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139154580 | CMS |
| MOTIVA USA, LLC | $159.28 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139154590 | CMS |
| MOTIVA USA, LLC | $38.33 | 10/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139154588 | CMS |
| REVANCE THERAPEUTICS, INC. | $52.63 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147911306 | CMS |
| Solta Medical, a division of Bausch Health US, LLC | $17.80 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143957232 | CMS |
| TELA Bio, Inc. | $69.98 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154191321 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.